Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

HCOLL > Parkinson's disease | > Flashcards

Parkinson's disease | Flashcards

1
Q

What is the incidence of PD per year?

A

4-20 in 100,000

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Approx how many people in the UK have PD?

A

120,000

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Of the people with PD in the UK, what proportion:

  1. Are in hospital/residential care
  2. In the community requiring help
  3. Are independent, living in the community
A
  1. 25%
  2. 33%
  3. 50%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are risk factors for PD?

  1. Definite (2)
  2. Highly likely (1)
  3. Probable (1)
  4. Possible (5)
  5. Possible protective effect (2)
A

Definite

  1. Age
  2. Men 1/3 higher risk than women

Highly likely
1. MZ co-twin with early-onset PD

Probable
1. Positive family history

Possible

  1. Herbicides / pesticides
  2. Heavy metals
  3. Proximity to industry
  4. Farming communities
  5. Repeated head trauma

Possible protective effect

  1. Smoking
  2. Caffeine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the pathological changes which occur in PD? (5)

A
  1. Dopaminergic cells in the substantia nigra (in basal ganglia) degenerate
  2. Leads to a reduced production of dopamine
  3. Striatal dopamine deficiency and PD symptoms
  4. Lewy bodies present at post mortem
  5. Midfolding of alpha-synuclein protein
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the normal function of the basal ganglia?

2

A
  1. Controls the preparation, initiation, sequencing and timing of well learnt motor skills
  2. ‘Auto pilot’ facility

When dopamine production is depleted it
leads to hypokinetic disorders such as PD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the different types of Parakinsonism? (6)

A
  1. Idiopathic Parkinsons disease (IPD)
  2. Lewy body dementia
  3. Multiple systems atrophy
  4. Progressive supranuclear palsy
  5. Vascular parkinsonism
  6. Drug-induced Parkinsonism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the 4 main features of PD?

A
  1. Bradykinesia
  2. Rigidity
  3. Resting tremor
  4. Postural instability
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What symptoms can predate motor symptoms of PD for several years (4)?

A
  1. Depression
  2. REM sleep disorder
  3. Anosmia
  4. Constipation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Around what % of dopamine producing cell loss occurs prior to diagnosis?

A

up to 80%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the motor symptoms in PD (9)?
3 main ones
6 others

A
  1. Tremor (resting) 70%
    - more noticeable at rest, when anxious, angry or
    excited. May decrease when the body part is used.
  2. Bradykinesia
    - harder to make movements and they take longer, slow movements. Reduced arm swing and small steps.
    - Decrimental bradykinesia
  3. Stiffness (rigidity)- trouble turning, getting out of a chair, difficulty with fine finger movement. Lead pipe/cog-wheeling

[2 is a must, +1 or 3]

  1. Postural Instability
  2. Dystonia- painful cramping often of the feet and legs and often worse at night. Off phase symptom.
  3. Freezing-often in confined spaces, on turning or sudden sensory input.
  4. Swallowing difficulties (dysphagia)
  5. Communication difficulties
  6. Dyskinesia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What % of people with PD have difficulty with some degree of swallowing difficulties?

A

50-80%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How do swallowing difficulties present (7)?

A
  1. Weight loss
  2. Drooling
  3. Anxiety at meal times
  4. Disturbed medication intake
  5. A ‘gurgly’ voice
  6. Decreased social contact
  7. Bronchopneumonia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the management of dysphasia (6)?

A
  1. Refer to SALT and dietician if necessary

Management focuses on:

  1. Positioning & posture
  2. Food consistency & temp
  3. Rate of eating
  4. Insight & cueing
  5. Saliva & drooling
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the communication difficulties that people with PD can face (3)?

A
  1. Voice can become harsh, breathy & whispery, monotonous & low volume
  2. Speech can become slurred, festinant with word blocks, increased pauses and have sound repetitions
  3. Individuals may have reduced understanding, disrupted thought planning, inappropriate stopping of sentences and be less likely to initiate conversation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the management of communication difficulties (3)?

A
  1. Exercises and strategies such as speaking one
    word at a time, pausing between words, use of metronome
  2. Advice regarding external distractions, positioning, allowing for thought processing, non verbal communication
  3. Communication aids such as voice amplifiers, alphabet or word chart, pen and paper, portable keyboard with speech output.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the unpredictable ‘ON-OFF’ phenomena in PD (5)?

A
  1. Sudden and unpredictable switches in mobility from mobile to immobile
  2. Patients may switch ON or OFF in seconds or minutes
  3. ‘Freezing’ may occur
  4. Often occur when patient experiences dyskinesia
  5. Profoundly akinetic when OFF and dyskinetic when ON
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How is the unpredictable ‘ON-OFF’ phenomena in PD treated?

A

Consider use of continuous dopaminergic stimulation

strategies such as longer acting oral agonists or apomorphine, duodopa or surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is the management of freezing (5)?

A
  1. Avoid multi tasking
  2. Do not rush
  3. Use visual, auditory or internal cues
  4. Physiotherapy- advice regarding cueing techniques, falls, balance
  5. OT - review of home environment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

How does dyskinesia present (2)?

A
  1. Uncontrollable wriggling or writhing movements
  2. Choreiform, usually painless, first appears on most affected side
  3. Can significantly interfere with gait, balance and
    quality of life
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is usually the cause of dyskinesia?

A

Increased risk from high doses and long duration of

treatment with L-dopa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

How is dyskinesia managed?

A

Careful management with combination of therapies is

often required

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are the non-motor symptoms that can occur in PD (11)?

A
  1. Olfactory deficiencies 98%
  2. Depression and anxiety
  3. Apathy
  4. Fatigue
  5. Bladder and bowel problems
  6. Pain
  7. Skin and sweating problems
  8. Sleep and night time problems REM sleep behaviour disorder 80%
  9. Sexual dysfunction
  10. Cognitive dysfunction and dementia
  11. Psychosis and hallucination
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is the management of depression and anxiety in PD?

A

Anti-depressants/b-blockers

Psychotherapy, CBT, relaxation techniques

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

How does incontinence usually present in PD (3)?

A
  1. Bladder dysfunction increases with disease progression
  2. Mainly detrusor over activity& bladder sphincter
    bradykinesia
  3. Worse in off state- frequency, urgency, urge
    incontinence, incomplete emptying, nocturia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What is the management of incontinence in PD (7)?

A
  1. Individual and specialist assessment
  2. Bladder retraining
  3. Pelvic floor exercises
  4. Indwelling or supra pubic catheter
  5. Appliances
  6. Fluid intake
  7. Clothing
27
Q

What are the features of constipation in PD (2)?

A
  1. Often precedes diagnosis
  2. Caused by reduced bowel motility, reduced physical mobility, inadequate fluid and fibre intake, problems emptying the bowel and some medications
28
Q

What is the management of constipation in PD (5)?

A
  1. fluid intake
  2. diet
  3. medications
  4. exercise
  5. position and habit
29
Q

What are the problems with saliva control in PD?

A

Caused by reduced swallowing, stooped

or poor posture and reduced lip seal

30
Q

What is the medical management of saliva problems in PD (6)?

A
  1. Atrovent inhaler
  2. Atropine eye drops
  3. Hyoscine patch (with caution)
  4. Botox
  5. Sage
  6. SALT: effective swallowing, posture and lip seal
31
Q

What are some night time problems that occur in PD?

A
  1. REM behaviour disorder- act out dreams which are vivid and often frightening.
  2. Restless legs- Unpleasant sensation with uncontrollable urge to move when at rest.
  3. Dystonia
  4. Wearing off
  5. Nocturia
32
Q

How is REM behaviour disorder managed?

A

Clonazepam

33
Q

How is restless legs managed (3)?

A
  1. Reducing alcohol, caffeine and tobacco intake
  2. Check Iron, folate
    and magnesium levels.
  3. Dopamine agonists
34
Q

How do you manage PD medication wearing off at night time?

A

Take last dose of PD medication as close to bedtime as possible

35
Q

What is the incidence of falls in people with PD every year?

A

45-68%

36
Q

What are some risk factors for falls specific to PD (5)?

A
  1. Cognitive impairment
  2. Postural instability/gait impairment
    - static
    - dynamic
  3. Reduced lower extremity strength/power
  4. Motor fluctuations and dyskinesia
  5. Freezing of gait/gait impairment
37
Q

What are negative consequences of falls in PD?

A
  1. Fractures, injuries and fear of falling
    - >
  2. Immobilisation
    - >
  3. Osteoporosis, social isolation, muscle weakness
    - >
  4. “Malignant Parkinson disease”, reduced quality of life, increased mortality
38
Q

In newly diagnosed untreated PD patients, what % have cognitive impairment with a MOCA of less than 26?

What are these people are at risk of?

A

22%

Developing dementia

39
Q

How much more likely are you to get dementia with PD compared to a healthy person?

A

6x

40
Q

According to Queen Square Brain Bank criteria, what are the core features for the diagnosis of PD dementia?

UK brain bank criteria

A

A dementia syndrome with insidious onset and slow progression, developing within the context of established Parkinson’s disease and diagnosed by history, clinical, and mental examination, defined
as:
1. Impairment in more than one cognitive domain
2. Representing a decline from premorbid level
3. Deficits severe enough to impair daily life (social, occupational, or personal care), independent of the impairment ascribable to motor or autonomic symptoms.

Step 1:
Bradykinesia and at least one of the following:
-muscular rigidity
rest tremor
postural insatbilty

Step 2
Exclusion

Step 3: supportive criteria

41
Q

What are the associated cognitive clinical features for the diagnosis of PD dementia (5)?

A
  1. Attention
    - Impairment in spontaneous and focused attention, may fluctuate during the day/from day to day
  2. Executive functions
    - Impairment in tasks requiring initiation,
    planning, concept formation, rule finding, set shifting or set maintenance; impaired mental speed (bradyphrenia)
  3. Visuo-spatial functions:
    - Impairment in tasks requiring visualspatial orientation, perception, or construction
  4. Memory:
    - Impairment in free recall of recent events or in tasks requiring learning new material, memory usually improves with cueing, recognition is usually better than free recall
  5. Language:
    -Core functions largely preserved. Word finding difficulties and impaired comprehension of complex sentences
    may be present
42
Q

What are the associated behavioural clinical features for the diagnosis of PD dementia (5)?

A
  1. Apathy:
    - Decreased spontaneity; loss of motivation, interest, and effortful behaviour
  2. Changes in personality and mood including
    depressive features and anxiety
  3. Hallucinations: mostly visual, usually complex,
    formed visions of people, animals or objects
4. Delusions: usually paranoid, such as infidelity, or
phantom boarder (unwelcome guests living in the home) delusions
  1. Excessive daytime sleepiness
43
Q

What % of patients with PD experience hallucinations at some point of disease?

A

80%

44
Q

What is the management of hallucinations and delusions in PD (8)?

A
  1. Avoidance of triggers
  2. Withdrawal of potentially contributing medications
  3. Adjustment of antiparkinsonian medications
  4. Introduction of cholinesterase inhibitors in patients with PD and dementia
  5. Treatment with antidepressants if psychosis is mood congruent in concomitant depression
  6. Atypical antipsychotics, clozapine or, possibly, quetiapine
  7. Clozapine more effective than placebo for the management of psychosis in PD but limited by its potential for severe side effects
  8. No large RCT has shown quetiapine to significantly improve psychosis in PD although it continues to be used empirically in clinical practice
45
Q

There is a higher prevalence of hallucinations and delusions in PD-D, what is the %

A

45-65%

46
Q

What are the characteristics of hallucinations in PD-D?

A
  1. Usually visual, majority are complex, formed hallucinations
  2. Most common are anonymous people, but
    they may also be family members, body
    parts, animals, or machines.
    • They tend to be in colour, static and
    centrally located, and occur with similar
    frequency and severity in PD-D and DLB
47
Q

When is palliative care sought in PD?

A

A situation where it is recognised that PD is going to be life-limiting, that death from PD or it’s complications can be anticipated, and that the focus of our therapy goals should be on the short term alleviation of symptoms

48
Q

What are the prognostic determinants in PD (4)?

A
  1. Age
  2. Genetic polymorphisms
  3. Poor semantic fluency
  4. Co-morbidities/frailty
49
Q

What are the causes of death in PD?

A
  1. Mechanisms of immobility
  2. Falls
  3. Chest and urinary infections
  4. Exhaustion
  5. Weight loss
50
Q

When do you begin treatment for PD?

A

As soon as you get first onset of symptoms

51
Q

What are the pharmacological treatments of PD (6)?

A
  1. Dopamine replacement
    Levodopa -> most effective symptomatic treatment
  2. Dopamine agonists e.g. ropinerole, pramipexole, rotigotine
  3. Selective irreversible inhibitor of monoamine oxidase-B e.g. Selegeline/Rasagaline
  4. MAO-B inhibitor with additional activity at non-MAO-B targets e.g. Safinamide
  5. Antiviral agent with models antiparkinsonian effect e.g. amantadine
  6. COMT inhibitors that block the metabolism of L-dopa e.g. entacapone, stalevo
52
Q

What is the most effective medication for PD?

A

Levodopa

53
Q

What is usually the response to levodopa over time?

A

Initial smooth response to l-dopa but complications arise after 4-6 years

54
Q

What is the benefit of a dopamine agonist (ropinerole, pramipexole, rotigotine) over levodopa?

A

Longer duration of action than l-dopa thus reduced pulsatility

55
Q

When would Selegeline (selective irreversible inhibitor of MAO-B) be used in PD (2)?

A
  1. Can delay introduction of l-dopa by aprox one year
  2. Can increase extent and duration of response to l-dopa
    in adjunct therapy
56
Q

When would amantadine (antiviral with modest antiparkinsonian effect) be used in PD?

A

Occasionally used in early disease to delay l-dopa but now more frequently for
anti-dyskinetic properties

57
Q

When would Rasagaline (potent, selective irreversible MAO-B inhibitor) be used in PD?

A

Provides symptomatic benefit in both early and advanced disease

58
Q

When would Safinamide (MAO-B inhibitor with non-MAO-B targets) be used in PD?

A

Add on treatment to other therapies in mid to

late stage PD

59
Q

When would COMT inhibitors in PD be used?

A

To improve ADL’s

60
Q

What is the advanced therapy - continuous levodopa infusion?

A
  1. Gel suspension (duodopa) for continuous enteral
    administration.
  2. Administered via a portable pump directly into the duodenum via a gastrostomy or jejunostomy
  3. Reduced variability in plasma concentrations of l-dopa clinically reflected as more on time per day, less
    parkinsonism and less l-dopa induced hyperkinesia
61
Q

What are some negative effects of dopamine agonists (2)?

A
  1. Can contribute to Compulsive tendencies including excessive gambling, punding, hobbyism, dietary changes and hypersexuality
  2. Compulsive use of dopaminergic medications
    escalated by the patient driven by an attempt to avoid
    the dysphoria of ‘off’ periods
62
Q

What are principle side effects of dopamine agonists (5)?

A
  1. Nausea & vomiting
  2. Postural hypotension
  3. Dyskinesia
  4. Neuropsychiatric symptoms - hallucinations
  5. Somnolence
63
Q

What are tests for PD?

A
  1. No definite test
  2. Brain imaging
    -CT/MRI - stroke/tumours/other
    DaT scan - dopamine depletion (if negative, you can exclude PD)

HCOLL (17 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions